Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region Project 1 - Epidemiology (ACHIEVE P1-EPI)
Part of paid clinical trials in Detroit, Michigan.
- Sponsor
- Wayne State University
- Study ID
- NCT06593496
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Text Message Reminder — BEHAVIORALRandomized selection of recruited participants that will receive text messages reminding them to take their blood pressure.
Study Details
This project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health In Populations Through Early PreVEntion in the GREAT LakEs Region) Center (IRB# 100221MP2A), the purpose of which is to improve cardiometabolic health in two uniquely comparable cities: Detroit, Michigan, and Cleveland, Ohio. The ACHIEVE GREATER Center involves separate but related projects that aim to improve cardiometabolic health outcomes through better risk factor control for three chronic conditions that are of tremendous public health importance, (hypertension (HTN), heart failure, and coronary heart disease), all of which contribute significantly to premature death in Detroit and Cleveland. The present study is the prospective observational cohort component of ACHIEVE P1- EPI (Project 1) of the ACHIEVE GREATER Center and serves to characterize the population of patients with blood pressure (BP) levels above normal attending The Wayne Health Mobile Health Unit (MHU) events to better understand key factors (e.g., social determinants of health) that convey information about baseline BP levels and related clinical outcomes (e.g., follow-up clinic visits, BP control, and cardiovascular events).
Key Dates
- Start date
- Jun 11, 2025
- Status verified
- Jul 2025
- Primary completion
- Jun 1, 2027
- Completion
- Jun 1, 2028
Study Design
- Enrollment
- 1,000 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: Text MessageParticipants assigned to the interventional group will receive a text message reminding them to take their blood pressure.
- No Intervention: Control/No Text MessageThose assigned to the usual care group will not receive a reminder text message.
Primary Outcome Measure
Measure Blood Pressure Protocol Fidelity [ Time Frame: 12 Months ]
Central Contacts
- Phillip Levy, MD, MPH313-577-1214
- Katee Dawood, MBA313-577-1232
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Wayne Health Mobile Units | Detroit | Michigan | 48201 | Laura Schulz Bethany Foster, MPH |
Find similar trials in Detroit, MI
Related Studies
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Group 1)EARLY_PHASE1 · Recruiting · Benjamin Viglianti · Ann Arbor, Michigan
- Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Groups 2, 3 & 4)EARLY_PHASE1 · Recruiting · Benjamin Viglianti · Ann Arbor, Michigan
- Project 2: ACHIEVE- HFRecruiting · Henry Ford Health System · Detroit, Michigan